SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

"What's Updog?" is a Community Led token.

UpDog

UpDog ($UPDOG.X) is trending as the community rallies around this Solana-based meme coin, emphasizing its commitment to donating to animal shelters. Community members are actively congratulating other trending tokens for being "UpDog", highlighting the coin's growing presence and positive sentiment. The coin's solid fundamentals, joke-inspired meta, and listing on Jupiter Exchange are also being discussed as drivers of its potential.

Pump.fun

$PUMP.X is trending as users discuss its potential as a memecoin launchpad on Solana, highlighting its revenue model and community growth. Community members are actively discussing entry points, price targets, and whether it can reach the levels of coins like $DOGE.X. Some are pointing to potential catalysts, like exchange listings and upcoming events, that could drive further momentum.

Flare is a blockchain for building applications that are interoperable with other blockchains and the internet.  ## What is Flare (FLR)?  Flare is an EVM-based Layer 1 blockchain designed to allow developers to build applications that are interoperable with blockchains and the internet. By providing decentralized access to high-integrity data, Flare enables new use cases and monetisation models.   ## What makes Flare unique?  Flare's native interoperability protocols, the State Connector and the FTSO are secured by the network itself, allowing it to reliably deliver data from a wide variety of off-chain sources in a decentralized way.   The Flare Time Series Oracle delivers highly-decentralized price and data feeds to dapps on Flare, without relying on centralized providers.   The State Connector protocols enable information, both from other blockchains and the internet to be used securely, scalably and trustlessly with smart contracts on Flare.  Risk is minimized by building this decentralized data infrastructure natively into the blockchain, powered by a large number of independent data providers.  By incentivizing sets of independent providers to query, acquire, and process data without relying on single, centralized sources, Flare’s core protocols can facilitate the development of interoperable dapps with a broad range of potential innovative use cases.   ## What is the Flare (FLR) token used for?  FLR is the native token used for payments, transaction fees to prevent spam attacks and staking in validator nodes. FLR can also be wrapped into an ERC-20 variant, WFLR. WFLR tokens serve various functions; they can be delegated to FTSO data providers, for example, or staked to participate in governance. These two uses are not mutually exclusive and do not prevent the tokens from being used in other EVM-compatible dapps and smart contracts on Flare.  Wrapped FLR (WFLR) can be minted by depositing native FLR tokens into a smart contract and withdrawing the newly minted

Spark Token

Spark Token ($FLR.X) is trending as community members discuss its potential within the XRP ecosystem and its possible integration with staking platforms. The recent buzz is fueled by news of adoption headlines and staking rewards via monthly airdrops. Some investors are optimistic about its long-term growth, drawing comparisons to other successful tokens and anticipating a significant rise in value.

BlackBerry Ltd

BlackBerry is trending as investors discuss its potential turnaround, highlighting key partnerships and the growing adoption of QNX in safety-critical systems. Community members are pointing to upcoming earnings as a possible catalyst, with some expressing optimism about revenue growth and margin expansion. The discussion also includes speculation around potential acquisitions and strategic moves, particularly related to its QNX and cybersecurity divisions.

SSgA Active Trust - SPDR Dow Jones Industrial Average ETF

DIA is trending as traders assess the potential impact of recent economic data, including a weaker-than-expected jobs report, on future Federal Reserve policy. Community discussions revolve around the likelihood of rate cuts and their potential effects, while some express concerns about market manipulation and the reliability of economic data. A court decision impacting tariffs is also adding to the uncertainty.

Dolomite

Dolomite (DOLO.X) is trending as community members discuss potential catalysts and compare it to other recently volatile altcoins. The community is speculating about factors driving the price and expressing excitement about potential gains. Mentions of related tokens and possible listings are circulating among traders.

HarryPotterObamaSonic10Inu (Ticker: BITCOIN) is a endgame of crypto-assets (0 Tax). BITCOIN incentivizes the creation of novel and entertaining meme content. With ownership renounced and Liquidity locked, our robust growing community has taken the lead; we have successfully completed a full audit, an NFT collection, and are exploring partnerships with other tokens in the space, a one-of-a -kind website, and one-of-a-kind merchandise and ecommerce site in the works based on the legendary meme that inspired BITCOIN's creation. Our goal is to create an ecosystem for active community members to meet, collaborate, and share our rich lore (the archive of our token's storied history) with the world.

hposI0iETH

Bitcoin's recent activity has spurred discussions around its potential to outperform traditional stocks, with community members analyzing chart patterns and debating future price movements. Some users are comparing it to other cryptocurrencies and memecoins, while others are discussing broader narratives around tokenization and the potential impact of regulatory approvals. The community also seems to be focused on the relationship between Bitcoin and specific altcoins.

GIGA is a meme token deployed on the Solana blockchain intended to honor the legend Ernest Khalimov the original “Gigachad”, by utilizing the strength of memes and “Chad” energy.  GIGA is a community run project.

GigaChad

GigaChad ($GIGA.X) is trending as community members discuss its potential within the meme coin sector, drawing comparisons to other popular coins and highlighting its strong community. Recent social media activity, including a YouTuber meeting the real Gigachad, may be contributing to the increased attention. Some traders are also watching its correlation to Solana ($SOL.X) for potential movement.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending amid discussions around its livestreaming capabilities following a recent boxing event, with debates over stream quality and potential partnerships with betting apps.  Speculation about Netflix bidding for Warner Bros. Discovery ($WBD) is also circulating, impacting investor sentiment. Additionally, some investors are discussing the potential impact of Netflix's political stances on the stock.

Direxion Shares ETF Trust - Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 2X Shares

Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 2X Shares

$GUSH is trending as traders discuss the potential impact of fluctuating oil prices and geopolitical tensions on the energy sector. Community members are actively sharing technical analysis, discussing potential entry points, and debating the influence of political factors on oil supply and demand. Overall sentiment seems cautiously optimistic, with many anticipating a potential upswing.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Shares of Aptevo Therapeutics Inc. (APVO) rocketed 41% on Thursday after the company <a target="_blank" rel="noopener noreferrer nofollow" href="https://aptevotherapeutics.gcs-web.com/news-releases/news-release-details/aptevo-therapeutics-21-million-registered-direct-offering-and">said</a> it is looking to raise about $2.1 million in a registered direct offering and warrants sale.The company said it has entered into definitive securities purchase agreements for the purchase and sale of 1.76 million shares of its common stock in a registered direct offering and warrants to purchase up to 3.5 million shares of common stock in a concurrent private placement at a combined purchase price of $1.19 per share and accompanying warrant.The warrants will have an exercise price of $1.19 per share and will expire five years from the initial exercise date.The offering is expected to close on or about April 4.The company will use the net proceeds from the offering for the continued clinical development of product candidates, as working capital, and for other general corporate purposes.On Stocktwits, retail investor sentiment about Aptevo jumped from ‘extremely bearish’ to ‘extremely bullish’ territory (97/100), hitting a one-year high. At the same time, message volume touched ‘extremely high’ levels.<figure class="image"><img style="aspect-ratio:652/153;" src="https://news.stocktwits-cdn.com/Screenshot_2025_04_03_at_11_35_45_AM_png_96a7494386.webp" alt="https://stocktwits.com/news-articles/markets/equity/trump-liberation-day-impact-steel-stocks-tumble-with-broader-market/chf7RL4RbeK" width="652" height="153"><figcaption>APVO's Sentiment Meter and Message Volume as of 11:35 a.m. ET on April 3, 2025 | Source: Stocktwits</figcaption></figure> A Stocktwits user opined that the registered direct offering may be a “bailout” to institutions who were short.&nbsp;<stembedurl>https://stocktwits.com/leon_dedrick/message/610264441</stembedurl>Another user, however, expressed optimism about the share price rising to $3.<stembedurl>https://stocktwits.com/Bulltacos/message/610259261</stembedurl><a href="https://stocktwits.com/symbol/APVO">APVO shares</a> have lost over 55% this year and nearly all its value over the past 12 months.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/trump-liberation-day-impact-steel-stocks-tumble-with-broader-market/chf7RL4RbeK">Trump’s Liberation Day Impact – Steel Stocks Tumble With Broader Market, UBS Flags Tariffs As 'Incremental Negative' For These Companies</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

Aptevo Stock Rises On $2.1M Registered Direct Offering, Warrant Sale: Retail  Sentiment Touches Year-High

The company said that net proceeds from the offering will be used for the continued clinical development of product candidates, as working capital, and for other general corporate purposes.

Equity

Aptevo Therapeutics Inc. shares surged nearly 50% early Thursday on promising leukemia trial results, before paring gains in volatile trading.&nbsp;The stock drew significant heavy interest on Stocktwits, reaching the top 15 trending symbols list, where sentiment turned ‘extremely bullish’ amid a sharp rise in message volume.<figure class="image"><img style="aspect-ratio:1314/320;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/APVO_sentiment_and_message_volume_on_Dec_12_f6c2ca53dd.png" alt="APVO sentiment and message volume on Dec 12.png" width="1314" height="320"><figcaption>APVO sentiment and message volume on Dec 12 as of 11:45 am ET | source: Stocktwits</figcaption></figure>The company announced that all patients with acute myeloid leukemia (AML) treated with its lead candidate, mipletamig, achieved remission within 30 days in a Phase 1b trial.&nbsp;This includes two patients who experienced complete remission with 100% cancer cell elimination.&nbsp;The trial is exploring mipletamig as frontline therapy in combination with venetoclax and azacitidine, the current standard of care for AML.Retail traders speculated heavily on the stock’s movements, attributing volatility to its small public float of around 500,000 shares.&nbsp;Optimistic users expressed confidence in the company’s long-term potential, with one noting that they had bought 1,000 shares of Aptevo.Aptevo’s oncology pipeline targets aggressive forms of cancer. Other highlights include:• ALG.APV-527: Currently in Phase 1 for 5T4-expressing solid tumors like breast, colon, and non-small cell lung cancers. Preliminary data presented at leading oncology conferences has been positive.• Other preclinical candidates, including APVO711 (immune checkpoint blockade and activator) and APVO603 (dual co-stimulatory solid tumor targeting), are designed for precision cancer treatments.Aptevo stock remains down over 96% year-to-date, reflecting other ongoing challenges. Its current market cap is just over $5 million.Still, retail investors remain cautiously optimistic for now as the company builds on promising clinical data while addressing broader market pressures.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Aptevo Therapeutics Stock Draws Retail Attention After Leukemia Trial Data: Retail Extremely Bullish

The company announced that all patients with acute myeloid leukemia treated with its lead candidate, mipletamig, achieved remission within 30 days in a Phase 1b trial.

Why Aptevo Therapeutics Stock Is Cratering

Aptevo announced the pricing of a public offering of 3,400,000 shares of its common stock or pre-funded warrants in lieu thereof and warrants to purchase up to an aggregate of 6,800,000 shares of its...

Aptevo Therapeutics (NASDAQ:APVO) Earns Hold Rating from Analysts at StockNews.com

StockNews.com assumed coverage on shares of Aptevo Therapeutics (NASDAQ:APVO - Free Report) in a research report report published on Tuesday morning. The brokerage issued a hold rating on the...

Aptevo Participating in The Springtime Partnering Event, a Bio-Europe Conference

SEATTLE, WA / ACCESSWIRE / March 18, 2024 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immuno-oncology therapeutics based on its...

Aptevo Therapeutics (NASDAQ:APVO) Now Covered by Analysts at StockNews.com

StockNews.com assumed coverage on shares of Aptevo Therapeutics (NASDAQ:APVO  Free Report) in a research note released on Sunday. The firm issued a hold rating on the biotechnology...

Aptevo Therapeutics, Immuron, CASI Pharmaceuticals among healthcare movers

Aptevo Therapeutics, Immuron, CASI Pharmaceuticals among healthcare movers...

Why Is Immuno-Oncology Focused Aptevo Therapeutics Stock Trading Higher On Thursday?

Interim results from the Phase 1 trial of ALG.APV-527 by Alligator Bioscience and Aptevo Therapeutics. Positive signs of clinical activity in breast cancer patients, with well-tolerated treatment and...

Aptevo Therapeutics trading resumes

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Aptevo Therapeutics trading halted, volatility trading pause

Aptevo Therapeutics, Inc. is a clinical-stage biotechnology company, which engages on developing novel immunotherapies for the treatment of cancer. Its pipeline APVO436, ALG.APV-527, and APVO603 were developed based on the ADAPTIR modular protein platform technology and APVO442 was developed based on the new ADAPTIR-FLE platform technology. The ADAPTIR and ADAPTIR-FLEX are capable of generating differentiated bispecific and multi-specific antibodies with potentially unique mechanisms of action for the treatment of different types of cancer. The company was founded in February 2016 and is headquartered in Seattle, WA.

Current Price	$1.47
Prev Close	$1.50
Open	$1.51
Dividend Yield	0.00%
50-Day Moving Average	$2.35
Beta	0.89
Avg. Volume	150,392.14
PE Ratio	0.00

52-Week High	$381.10
52-Week Low	$1.43
Market Capitalization	$4.83M
EPS (Annual)	-$1,747.68
Price to Book	0.73
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

APVO
Aptevo Therapeutics Inc

Feed

News

Sentiment

Fundamentals

Info

Latest APVO News

APVO Aptevo Therapeutics Inc